InfoRLife SA
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Switzerland
- Registered address
- Casai, Campascio, 7748, Switzerland (CHE)
- Operations here
- analysislabelmanufacturepacksterilize
- FDA identifiers
- FEI 3004537783 · DUNS 481732753
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-05-03
- NAIDrug Quality Assurance2019-09-10
- NAIDrug Quality Assurance2018-02-23
- NAIDrug Quality Assurance2016-08-16
- NAIDrug Quality Assurance2013-07-04
- VAIDrug Quality Assurance2011-04-05
Drugs this plant is listed as making
9 distinct drugs across 24 products name this site in their FDA label.
- acetaminophenWG Critical Care, LLC
- Calcium GluconateWG Critical Care, LLC
- Diltiazem HydrochlorideWG Critical Care, LLC
- EdaravoneSandoz Inc
- LevofloxacinWG Critical Care, LLC
- Magnesium SulfateWG Critical Care, LLC
- Metronidazolein shortageWG Critical Care, LLC
- Midazolamin shortageWG Critical Care, LLC.
- Norepinephrine BitartrateWG Critical Care, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.